|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on May 29, 2007
Accepted on October 2, 2007
Molecular Diagnostics and Genetics |
1 Department of Cardiovascular Genetics, University College London, 5 University Street, London, United Kingdom
2 Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, University of Western Australia, Perth, Australia
3 Clinical Biochemistry, Western Australia Centre for Pathology and Medical Research, University of Western Australia, Perth, Australia
4 Sir Charles Gairdner Hospital Campus, Heart Research Institute of Western Australia, Perth, Australia, and School of Medicine and Pharmacology, University of Western Australia, Perth, Australia
5 Sir Charles Gairdner Hospital Campus, Heart Research Institute of Western Australia, Perth, Australia
* To whom correspondence should be addressed. E-mail: rmhaseh{at}ucl.ac.uk.
Background: Interleukin (IL)-18 is a proinflammatory cytokine that has been implicated in several diseases, including atherosclerosis, and increased circulating IL-18 concentrations increase risk of future coronary heart disease (CHD). We evaluated the effect of common variation within the IL18 gene on concentrations of circulating IL-18.
Methods: We measured IL-18, by ELISA, in the population-based study group [Carotid Ultrasound Disease Assessment Study (CUDAS)] and a predominantly male cohort with premature cardiovascular disease [Carotid Ultrasound in Patients with Ischaemic Heart Disease (CUPID)]. Using a tagging single-nucleotide polymorphism (SNP) approach that captured >90% of genetic variation, we identified 4 common (>10%) haplotypes.
Results: A common SNP was associated with differences in IL-18 concentrations; in CUDAS individuals carrying 2 copies of the rare allele, concentrations were 13% higher than in those with no copies (P = 0.002). Haplotypes were also associated with significant differences in IL-18 concentrations in CUDAS and CUPID. Haplotype GTATA (frequency 23%) was associated with significantly lower IL-18 than others. In CUDAS, those carrying 2 copies had IL-18 concentrations 15% lower than those carrying no copies (P = 0.002); in CUPID, the difference was 22% (P = 0.004). These associations remained significant after adjustment for age, sex, hypertension, HDL cholesterol, waist-to-hip ratio, and alcohol consumption. Despite being associated with differences in IL-18 concentrations, the haplotypes did not occur at different frequencies in those with or without carotid atherosclerotic plaques.
Conclusions: Variation within IL18 affects IL-18 concentrations in healthy and diseased individuals and thus may influence the pathophysiology of plaques at all stages of CHD progression.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |